Stay updated on Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check10 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.SummaryDifference1.0%
- Check18 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.9%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version v2.10.2 to v2.10.3.SummaryDifference0.1%
- Check53 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check75 days agoChange DetectedThe study has been updated to version v2.10.0 and now includes 2 locations, replacing the previous version v2.9.7.SummaryDifference0.4%
Stay in the know with updates to Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.